NCT00000271View on ClinicalTrials.gov

New Approaches to Cocaine Abuse Medications (A) - 6

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 31, 1995

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Cocaine-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Desipramine

Participants were treated with desipramine, up to 300 mg per day, or matching placebo. All participants received weekly individual manual-guided relapse prevention therapy.

DRUG

Placebo

Participants were treated with matching placebo. All participants received weekly individual manual-guided relapse prevention therapy.

Trial Locations (1)

10032

Research Foundation for Mental Hygiene, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER